E-Newsletters

VuePoint digital and print media (Optik Info, Optik Xtra and Optik Magazine) are distributed free of charge.

Featured Posts

Transitions Announces Canadian Consumer Media Campaign for 2023

Campaign features TV along with Spotify and YouTube among a variety of digital activations, as well as a continued partnership with Golf Canada including an educational, on-site activation

Learn More

opti Team Presents Concept and Content for 2024

Strategic expansion of the event and networking with industry and ophthalmic optics: opti is back!

Read more

Wearing Sunglasses Year-round Is Crucial to Maintain Optimal Eye Health

Regular sunglass use reduces exposure to UV rays and the risk of developing cataracts later in life

Read more

Azur by Morel

Designed for the cosmopolitan man, this model, from the Glacier concept, reflects the amalgam of a sporty style to an urban look.

Read more

Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa

Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301.

Read more

Transitions Announces Canadian Consumer Media Campaign for 2023

Campaign features TV along with Spotify and YouTube among a variety of digital activations, as well as a continued partnership with Golf Canada including an educational, on-site activation

Learn More

opti Team Presents Concept and Content for 2024

Strategic expansion of the event and networking with industry and ophthalmic optics: opti is back!

Read More

Wearing Sunglasses Year-round Is Crucial to Maintain Optimal Eye Health

Regular sunglass use reduces exposure to UV rays and the risk of developing cataracts later in life

Read More

Azur by Morel

Designed for the cosmopolitan man, this model, from the Glacier concept, reflects the amalgam of a sporty style to an urban look.

Read More

Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa

Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301.

Read More

Transitions Announces Canadian Consumer Media Campaign for 2023

Campaign features TV along with Spotify and YouTube among a variety of digital activations, as well as a continued partnership with Golf Canada including an educational, on-site activation

Learn More

opti Team Presents Concept and Content for 2024

Strategic expansion of the event and networking with industry and ophthalmic optics: opti is back!

Read more

Wearing Sunglasses Year-round Is Crucial to Maintain Optimal Eye Health

Regular sunglass use reduces exposure to UV rays and the risk of developing cataracts later in life

Read more

Azur by Morel

Designed for the cosmopolitan man, this model, from the Glacier concept, reflects the amalgam of a sporty style to an urban look.

Read more

Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa

Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301.

Read more

Transitions Announces Canadian Consumer Media Campaign for 2023

Campaign features TV along with Spotify and YouTube among a variety of digital activations, as well as a continued partnership with Golf Canada including an educational, on-site activation

Learn More

opti Team Presents Concept and Content for 2024

Strategic expansion of the event and networking with industry and ophthalmic optics: opti is back!

Read more

Wearing Sunglasses Year-round Is Crucial to Maintain Optimal Eye Health

Regular sunglass use reduces exposure to UV rays and the risk of developing cataracts later in life

Read more

Azur by Morel

Designed for the cosmopolitan man, this model, from the Glacier concept, reflects the amalgam of a sporty style to an urban look.

Read more

Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa

Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301.

Read more